Skip to content

Author

Atsuto Katano

6 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Definitive Chemoradiotherapy for Cervical Esophageal Squamous Cell Carcinoma: A Single-institution Retrospective Study

Background/Aim The aim of the present study was to evaluate clinical outcomes of radiotherapy-based treatment in patients with previously untreated cervical esophageal squamous cell carcinoma at a single institution. Patients and Methods We retrospectively analyzed consecutive patients who received curative-intent radi...

Atsuto Katano, Hideomi Yamashita · 0 citations
Open access Oct 2026

Five-fraction stereotactic body radiotherapy for prostate cancer in octogenarians and nonagenarians: A single-institution retrospective cohort study.

The incidence of prostate adenocarcinoma (PCa) increases with age. Stereotactic body radiotherapy (SBRT) is a curative option; however, the evidence in elderly patients remains limited. This single-institution retrospective cohort study included consecutive patients aged ≥80 years with localized PCa treated with defini...

Atsuto Katano, Hideomi Yamashita · 0 citations
Review Open access Oct 2026

Linear Accelerator-Based Stereotactic Body Radiotherapy of 36.25 Gy in Five Fractions for Localised Prostate Cancer: A Retrospective Single-Institution Cohort Study.

BACKGROUND Stereotactic body radiotherapy has become an established treatment option for localised prostate cancer. However, real-world evidence from routine clinical practice remains limited, particularly in cohorts that include older patients. We therefore report long-term outcomes and treatment-related adverse event...

Atsuto Katano, Hideomi Yamashita · 0 citations
Open access Sep 2026

Minimal Target Embolization of High-Risk Component in Brain Arteriovenous Malformation Combined with Stereotactic Radiosurgery: a Proof-of-Concept Study.

BACKGROUND Brain arteriovenous malformations (AVMs) with high-risk angioarchitecture features are associated with the risk of hemorrhage. This study evaluated the safety and effectiveness of a combined approach involving targeted embolization of high-risk components and stereotactic radiosurgery (SRS). METHODS This s...

S. Koizumi, M. Umekawa, Shinya Yuki et al. · 0 citations
Review Open access Sep 2026

36.25 Gy versus 40 Gy in five fractions of curative stereotactic body radiotherapy for prostate cancer: a propensity score-matched analysis

The findings suggest that the 36.25-Gy regimen may be non-inferior to 40 Gy for EFS and may be associated with fewer grade 4 toxicities and better urinary QOL and should be considered hypothesis-generating.

Hideomi Yamashita, Daichi Sugahara, S. Sawayanagi et al. · 0 citations
Open access Sep 2026

Efficacy and safety of risk-adapted modified stereotactic body radiotherapy for lung tumors: a single-institution retrospective study.

Risk-adapted SBRT with increased fractionation demonstrated encouraging LC while maintaining an acceptable toxicity profile for central and ultracentral lung tumors, however, the risk of severe toxicity remains, requiring careful patient selection and optimized OAR dose constraints.

Akiko Oka, Hideomi Yamashita, Y. Miki et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.